Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Balchem Corp(BCPC US)

$177.00+3.772.18%Ext:$159.59-17.419.84%(Market Closed · 23:47:14 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
BCPC US​

Balchem Corp — Company Profile

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Sector
Basic Materials
Industry
Chemicals - Specialty
Exchange
UQ
CEO
Theodore L. Harris
Headquarters
Montvale, NJ, US
IPO Date
Jun 3, 1986
Employees
1,379
Website
www.balchem.com

Key Metrics

Price
$166.56
Market Cap
$5.35B
Revenue (TTM)
$270.71M
Net Income (TTM)
$40.28M
EPS (TTM)
1.25
P/E (TTM)
33.85
P/B (TTM)
4.16
Dividend Yield
61.29%
ROE (TTM)
3.13%
ROA (TTM)
2.38%
Operating Margin
20.55%
Beta
0.18

Dividends

Last Dividend
$0.96
Last Yield
0.61%

Summary

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Website
www.balchem.com
Location
Montvale, NJ, US
Phone845 326 5600
Employees1,379
CEOTheodore L. Harris
SectorBasic Materials
IndustryChemicals - Specialty
IPO DateJun 3, 1986

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(1.3K)

Expand
  • 10-QQ3ended 30 Sept 202623 Oct
  • 8-KResults of Operations and Financial Condition23 Oct
  • 3Initial statement of beneficial ownership24 Sep
  • 10-QQ2ended 30 Jun 202631 Jul
  • 8-KResults of Operations and Financial Condition31 Jul
  • 8-KEntry into a Material Definitive Agreement24 Jul
  • 8-KSubmission of Matters to a Vote of Security Holders22 Jun
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)18 Jun
  • 10-QQ1ended 31 Mar 202630 Apr
  • 8-KResults of Operations and Financial Condition30 Apr
  • SC 13GBALCHEM CORP29 Apr
  • SC 13GBALCHEM CORP28 Apr
  • DEFA14ADefinitive additional materials27 Apr
  • DEF 14ADefinitive proxy statement27 Apr
  • 3Initial statement of beneficial ownership7 Apr
  • SC 13G/ABALCHEM CORP26 Mar
  • 10-KFY 2025ended 31 Dec 202520 Feb
  • 8-KResults of Operations and Financial Condition20 Feb
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers19 Feb
  • 4Statement of changes in beneficial ownership13 Feb

News

  • Balchem: 3 Key Takeaways for Long-Term Investors23 Oct
  • Balchem Corporation (BCPC) Q3 2026 Earnings Call Transcript23 Oct
  • Balchem Corporation Reports Third Quarter 2026 Financial Results23 Oct
  • Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 20269 Oct
  • Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 20269 Sep
  • Balchem: It's A Buy From Me After Posting Strong Q2 Results1 Aug
  • Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript31 Jul
  • Conestoga SMid Cap Composite Q2 2026 Portfolio Review31 Jul
  • Balchem Corporation Reports Second Quarter 2026 Financial Results31 Jul

Mentions in Filings

  • #\*Arq, Inc. 107,594 383,035 \*Ascent Industries Co. 30,426 493,205 Ashland, Inc. 137,161 8,388,767 \*Aspen Aerogels, Inc. 217,839 734,117 Avient Corp. 284,009 10,266,925 \*Axalta Coating Systems, Ltd. 598,384 20,093,735 <strong>Balchem</strong> Corp. 98,248 16,718,862 Cabot Corp. 166,805 12,041,653 Caledonia Mining Corp. PLC 42,745 1,172,923
    Dimensional ETF TrustBalchem Corp·NPORT-EX - NT NPORT-P - Notification of late filing (portfolio holdings)·Q1 26·13 Aug
  • … | remarks | | unit price | Amount | | | | | | US dollars | PERMIAN RESOURCES CORP | 11,250 | 19.26 | 216,675.00 | | | TIDEWATER INC | 4,260 | 74.22 | 316,177.20 | | | | AVIENT CORP | 7,760 | 36.52 | 283,395.20 | | | | <strong>BALCHEM CORP</strong> | 2,790 | 165.34 | 461,298.60 | | | | APPLIED INDUSTRIAL TECH INC | 1,750 | 318.89 | 558,057.50 | | | | BWX TECHNOLOGIES INC | 1,370 | 194.68 | 266,711.60 | | | | ESCO TECHNOLOGIES INC | 1,640 | 315.92 | 518,108.80 | | …
    SBIアセットマネジメント株式会社Balchem Corp·Prospectus - Securities registration statement·11 Sep·10 Sep
  • … 887 | 41,627.05 | 84,086,646 | 1.89 | | America | stock | IONIS PHARMACEUTICALS INC | Pharmaceuticals, Biotechnology, Life Sciences | 6,180 | 11,987.62 | 74,083,552 | 13,103.24 | 80,978,079 | 1.82 | | America | stock | <strong>BALCHEM CORP</strong> | material | 2,790 | 26,849.56 | 74,910,279 | 27,478.01 | 76,663,653 | 1.73 | | America | stock | WINTRUST FINANCIAL CORP | bank | 2,880 | 25,308.48 | 72,888,427 | 26,042.48 | 75,002,355 | 1.69 | | America | stock | GL …
    SBIアセットマネジメント株式会社Balchem Corp·Annual Report - Annual Securities Report (2025.06.13-2026.06.12)·11 Sep·10 Sep
  • … | | | | --- | --- | | • ASP Isotopes Inc. (NasdaqCM:ASPI) • Comstock Inc. (NYSEAM:LODE) • Perimeter Solutions, Inc. (NYSE:PRM) • <strong>Balchem Corp</strong>oration (NasdaqGS:BCPC) • Ecolab Inc. (NYSE:ECL) • Albemarle Corporation (NYSE:ALB) • Sociedad Química y Minera de Chile S.A. (NYSE:SQM) • The Sherwin-Williams Company (NYSE:SHW) • Solstice Advanced Materials, Inc. (NasdaqGS:SOLS) • Element Solutions Inc (NYSE:ESI) • DuPont de Nemours, Inc. (NYSE:DD) | • Min …
    DevvStream Corp.Balchem Corp·DEFM14A - PROXY STATEMENT·Q1 27·3 Aug
  • … | | | | --- | --- | | • ASP Isotopes Inc. (NasdaqCM:ASPI) • Comstock Inc. (NYSEAM:LODE) • Perimeter Solutions, Inc. (NYSE:PRM) • <strong>Balchem Corp</strong>oration (NasdaqGS:BCPC) • Ecolab Inc. (NYSE:ECL) • Albemarle Corporation (NYSE:ALB) • Sociedad Química y Minera de Chile S.A. (NYSE:SQM) • The Sherwin-Williams Company (NYSE:SHW) • Solstice Advanced Materials, Inc. (NasdaqGS:SOLS) • Element Solutions Inc (NYSE:ESI) • DuPont de Nemours, Inc. (NYSE:DD) | • Min …
    XCF Global, Inc.Balchem Corp·424B3 - PROSPECTUS·Q3 26·31 Jul
  • … | | | | --- | --- | | • ASP Isotopes Inc. (NasdaqCM:ASPI) • Comstock Inc. (NYSEAM:LODE) • Perimeter Solutions, Inc. (NYSE:PRM) • <strong>Balchem Corp</strong>oration (NasdaqGS:BCPC) • Ecolab Inc. (NYSE:ECL) • Albemarle Corporation (NYSE:ALB) • Sociedad Química y Minera de Chile S.A. (NYSE:SQM) • The Sherwin-Williams Company (NYSE:SHW) • Solstice Advanced Materials, Inc. (NasdaqGS:SOLS) • Element Solutions Inc (NYSE:ESI) • DuPont de Nemours, Inc. (NYSE:DD) | • Min …
    XCF Global, Inc.Balchem Corp·S-4/A - REGISTRATION STATEMENT·Q3 26·27 Jul

Key Stats

Trading

Px/Chg 1D$166.56 / +1.75%
Prev Close$171.61
% of 52Wk H92.75%
Avg Volume208.67K
Beta0.18
Mkt Cap5.35B
FD Mkt Cap5.48B

Float

Shrs Out/Float32.13M / 31.95M
Short Float0.02%
Days to Cover1.56
Stock Repurchased$15.69M

Current Valuation

EV5.46B
EV/EBITDA20.19
EV/Sales5.17
P/B4.16
P/S5.06
FCF Yield0.63%
ROE3.13%
ROA2.38%
Current Ratio2.55

Dividend

Cash$0.96
Yield61.29%
Yield (TTM)61.29%

Estimates

P/E33.85
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgApr '23May '24Apr '25Apr '26Oct '26
PRICE-BASED RATIOS
Price / Earnings79.2538.3843.2739.84142.82131.95
Price / Sales11.134.295.095.3721.2519.64
Price / Book Value4.364.314.464.454.464.14
Price / Free Cash Flow75.9945.8232.2034.98109.71157.22
ENTERPRISE VALUE METRICS
Enterprise Value5,164.84,437.74,962.65,277.05,719.55,427.4
Enterprise Value / Sales11.474.715.385.5321.7020.05
Enterprise Value / EBITDA47.9022.6623.1022.8590.1680.73
Enterprise Value / EBIT59.8830.8131.0428.84109.5499.16

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue6.7%799.0942.4922.4953.71,037.2
Gross Income11.1%243.2280.5302.1336.2370.6
EBITDA9.6%176.6195.9214.8231.0254.4
EBIT13.1%127.7144.0159.9183.0209.2
Net Income12.7%96.1105.4108.5128.5154.8
EPS (Diluted)12.7%2.943.253.353.934.75
BALANCE SHEET
Cash & ST Inv-7.8%103.266.664.449.574.6
Total Assets9.2%1,199.31,624.51,597.21,575.41,707.6
Total Liabilities8.7%322.3686.2543.2425.5450.1
Total Shareholder Equity9.4%877.0938.31,054.01,149.91,257.4
CASH FLOW
Net Operating Cash Flow7.8%160.5138.5183.8182.0216.6
Cap Ex3.8%-37.4-50.3-37.9-35.7-43.5
Free Cash Flow8.9%123.188.2145.9146.3173.1

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)177.03
Basic Shares32.13
Market Cap5,688.0
Diluted Shares32.28
Fully Diluted Shares Outstanding32.28
Fully Diluted Market Cap5,715.3
+Consolidated Debt184.7
−In-the-Money Convertible Debt—
+Capital Leases15.7
+Operating Leases—
−Cash & Equivalents-72.9
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value5,799.8

Segment data

Revenue

by Products and services

  • Product Sales100%
  • Royalty0%

Revenue

by Geography

  • United States73%
  • Non-us27%

Related companies

Akzo Nobel Nv

AKZOY US

Solstice Advanced Materials Inc.

SOLS US

Ingevity Corp

NGVT US

Innospec Inc.

IOSP US

Chemours Co

CC US

OLIN Corp

OLN US

Huntsman CORP

HUN US

Fmc Corp

FMC US

Standard Lithium Ltd.

SLI US

Aduro Clean Technologies Inc.

ADUR US

Biolargo, Inc.

BLGO US

Loop Industries, Inc.

LOOP US